Prompting Prions

Credit: © Russell Kightley / rkm.com.au" /> Credit: © Russell Kightley / rkm.com.au The paper: Deleault et al., "Formation of native prions from minimal components in vitro," Proc Natl Acad Sci, 104: 9741-6, 2007. (Cited in 53 papers) The finding: To test whether misfolded, disease-causing prion proteins could form from their normal counterparts without being see

Written byTia Ghose
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:

Deleault et al., "Formation of native prions from minimal components in vitro," Proc Natl Acad Sci, 104: 9741-6, 2007. (Cited in 53 papers)

The finding:

To test whether misfolded, disease-causing prion proteins could form from their normal counterparts without being seeded with the infectious form, biochemist Surachai Supattapone and his colleagues at Dartmouth Medical School in Hanover, NH, mixed a cocktail of purified, uninfectious prions, a synthetic, highly charged RNA, and some lipids. After stirring the concoction with sound waves, the normal proteins morphed into their lethal cousins and triggered scrapie—a fatal prion disease—when injected into hamsters.

The impact:

The study was the first showing that fully infectious proteins can be created from scratch, "even without adding any infectious material in the reaction," says Ilia Baskakov, a biochemist at the University of Maryland Biotechnology Institute in Baltimore. "It's one of the milestones in the field."

The follow-up:

In ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies